3-Chloro-6-(1,3-dimethyl-1H-pyrazol-4-yl)pyridazine

Catalog No.: 
ACLQUS879
CAS No.: 
1467445-44-8
Molecular Formula: 
C9H9ClN4
Molecular Weight: 
208.65
3-Chloro-6-(1,3-dimethyl-1H-pyrazol-4-yl)pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$289.00InquiryInquiry
100mg98%$421.00InquiryInquiry
250mg98%$591.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-6-(1,3-dimethyl-1H-pyrazol-4-yl)pyridazine
IUPAC Name3-chloro-6-(1,3-dimethyl-1H-pyrazol-4-yl)pyridazine
MDL No.MFCD21179193
Molecular FormulaC9H9ClN4
Molecular Weight208.65
SMILESCC1=NN(C)C=C1C2=NN=C(Cl)C=C2
InChI KeyRPCXMWAVICKMQL-UHFFFAOYSA-N
Synonym3-chloro-6-(1,3-dimethyl-1H-pyrazol-4-yl)pyridazine;Pyridazine, 3-chloro-6-(1,3-dimethyl-1H-pyrazol-4-yl)-
CAS No.1467445-44-8

Synthetic Route by SureRoute

1. ACLQUS879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSQTE913 route compound structure diagram
    ACSQTE9131046832-21-6In Stock
  2. Plus
  3. ACNROZ260 route compound structure diagram
    ACNROZ260141-30-0In Stock
  4. Then
  5. ACLQUS879 route product structure diagram
    ACLQUS8791467445-44-8
Inquiry

2. ACLQUS879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSQTE913 route compound structure diagram
    ACSQTE9131046832-21-6In Stock
  2. Plus
  3. ACQFRX407 route compound structure diagram
    ACQFRX40789089-18-9In Stock
  4. Then
  5. ACLQUS879 route product structure diagram
    ACLQUS8791467445-44-8
Inquiry

3. ACLQUS879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKXZ841 route compound structure diagram
    ACCKXZ8411146616-03-6In Stock
  2. Plus
  3. ACNROZ260 route compound structure diagram
    ACNROZ260141-30-0In Stock
  4. Then
  5. ACLQUS879 route product structure diagram
    ACLQUS8791467445-44-8
Inquiry

Comments (0)